Ceva Launches MarboxidinTM – The NEW Tasty And Cost-effective Marbofloxacin

Ceva Animal Health has launched MarboxidinTM chewable tablets for dogs and cats for the treatment of micro-organisms susceptible to marbofloxacin. These include skin and soft tissue infections (in cats and dogs), respiratory tract infections (in dogs and cats) and urinary tract infections (in dogs). Containing marbofloxacin as its active ingredient, Marboxidin benefits from taste-masking lipid coating technology to ensure that its bitterness is not detected. In palatability trials over 90% of dogs and 80% of cats voluntarily consumed Marboxidin chewable tablets from the hand or in food¹. Marboxidin is also very cost-effective, with an ongoing discount using the new CevaSave rebate scheme. Marboxidin chewable tablets are available in three tablet sizes (5mg, 20mg and 80mg). Marboxidin is part of Ceva’s CevolutionTM range of high quality anti-infectives. For further details, please contact your Ceva Territory Manager of telephone the customer support team on (01494) 781510. Palatability study number LAV028/2012 in Marboxidin MA file

More from

• Animus launches SkinBond Multi for enhanced wound care
• IVC Evidensia reports 82% cut in Farm antibiotic use and 20% carbon emissions reduction
• Vet professionals flock to sign up to transformative locum platform
• The ProSalus Foundation launches urgent appeal for UK vets to support Ukrainian colleagues
• Vetsure Named Business of the Year at 2025 SME National Business Awards